Select a community
All Communities
Home > Community Treatment Reports > Sanctura Treatment Report
What is Sanctura?

Sanctura is a brand name for the drug Trospium Chloride, used in the treatment of overactive bladder symptoms such as incontinence, urgency, and frequency.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Bladder problems 17 1
Other 2 2
Urinary urgency 2 2
Slow my MS progress 1 0
Urinary frequency 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 20%
Mild
2 40%
None
2 40%

Most commonly reported side effects

dry mouth
3 60%
Constipation
1 20%
  • Mild
  • Moderate
  • Severe

Dosages

  20mg as needed daily 12.5 mg daily 20 mg daily 20 mg one time 40 mg daily 60 mg daily
  1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1 8 Number of Patients: 8 4 Number of Patients: 4  

Stop Reasons

Why Patients Stopped Taking Sanctura (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
2 67% Did not seem to work: 67%
Doctor's advice
2 67% Doctor's advice: 67%
Personal research
1 33% Personal research: 33%
Other
1 33% Other: 33%

See all 3 patients who’ve stopped taking Sanctura

Currently Taking Sanctura

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
4
7
4

Stopped Taking Sanctura

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
3
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
5 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 20%
Not at all
4 80%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 20%
$25-49
0 0%
< $25
3 60%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.